News & Publications for:

David Holtzman

Diagnostic and prognostic utility of the synaptic marker neurogranin in Alzheimer disease

Posted on May 26, 2016

Rawan Tarawneh, Gina D’Angelo, Dan Crimmins, et al: JAMA Neurol. 2016;73(5):561-571. doi:10.1001/jamaneurol.2016.0086. Read More

Posted in: Clocks & Sleep, HPAN, Neurodegeneration, Neurogenetics, Neurovascular Injury & Repair, Publications Faculty: , , ,

A spectrum of exercise training reduces soluble Aβ in a dose-dependent manner in a mouse model of Alzheimer’s disease

Posted on January 14, 2016

Moore, KM, Girens, RE, Larson, SK, et. al: 2016 Neurobiology of Disease, vol85, pp218-224 Read More

Posted in: Clocks & Sleep, HPAN, Neurodegeneration, Publications Faculty: ,

Microrna-33 regulates apoe lipidation and amyloid-β metabolism in the brain

Posted on November 16, 2015

Kim, J. et al.; 2015 Journal Neuroscience. 35(44), pp 14717-14726 Read More

Posted in: Clocks & Sleep, HPAN, Neurodegeneration, Publications Faculty: ,